Abstract
Owing to the ubiquitous availability and simple biocatalysis, the anti-proliferative laccase holds enormous opportunities for anti-cancer applications. However, accessing efficient and specific (super-magnetically targetable) new delivery system for anti-proliferative laccase is vital step towards laccase based anti-cancer approach. Therefore, in this investigation, super-magnetized (Fe3O4) and chitosan (CS) functionalized halloysite nanotubes (HNTs) (termed as Fe3O4-HNTs-CS) was facile synthesized. Further, laccase from Trametes versicolor was immobilized on Fe3O4-HNTs-CS (termed as Fe3O4-HNTs-CS-Lac). Then free laccase and Fe3O4-HNTs-CS-Lac were evaluated for anti-proliferative properties against cancer cell lines of liver (HepG2), lung (H460), cervix (Hela) and stomach (AGS). Laccase and Fe3O4-HNTs-CS-Lac gave significant cytotoxicity against all studied cancer cell lines. Moreover, the apoptosis analysis and FE-SEM morphology observations of cells support the anti-proliferative potential of laccase immobilized on Fe3O4-HNTs-CS. Therefore, investigated Fe3O4-HNTs-CS-Lac is natural and super-magnetic nano-biocatalyst, having the significant anti-proliferative potential and furthermore, Fe3O4-HNTs-CS can be used as efficient and specific delivery system for other anti-cancer enzymes.
| Original language | English |
|---|---|
| Pages (from-to) | 228-237 |
| Number of pages | 10 |
| Journal | International Journal of Biological Macromolecules |
| Volume | 118 |
| DOIs | |
| State | Published - 15 Oct 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-proliferative laccase
- Halloysite nanotubes
- Super-magnetic drug carrier
- Trametes versicolor laccase
Fingerprint
Dive into the research topics of 'Anti-proliferative applications of laccase immobilized on super-magnetic chitosan-functionalized halloysite nanotubes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver